Asset Details
Do you wish to reserve the book?
The Masked Thalassemia: A Rare Case of a Patient with Normal HbA.sub.2 Levels, beta-Thalassemia Pathogenic Variant
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The Masked Thalassemia: A Rare Case of a Patient with Normal HbA.sub.2 Levels, beta-Thalassemia Pathogenic Variant
Do you wish to request the book?
The Masked Thalassemia: A Rare Case of a Patient with Normal HbA.sub.2 Levels, beta-Thalassemia Pathogenic Variant
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The Masked Thalassemia: A Rare Case of a Patient with Normal HbA.sub.2 Levels, beta-Thalassemia Pathogenic Variant
2025
Overview
Thalassemia is a group of inherited blood disorders caused by defects in hemoglobin production, the protein that transports oxygen in red blood cells. These diseases are characterized by either diminished or missing production of one of the globin chains, which are often the alpha or beta chains that comprise hemoglobin. Diagnosis is based on a combination of laboratory tests, including hemoglobin electrophoresis, globin chain chromatography, and genetic analysis. However, diagnosis can become challenging when typical hematological features of thalassemia are not matched by expected biochemical findings. One such situation occurs when Hb[A.sub.2] levels appear normal despite a suspected [beta]-thalassemia trait. This can happen when a [beta]- globin gene variant is present alongside a [delta]-globin gene pathogenic variant, producing an atypical profile that may mask the true diagnosis. In this case report, we describe a patient carrying a heterozygous [beta]-globin pathogenic variant (HBB c.118C>T; p.Gln40Ter, also known as codon 39) coexisting with a large novel 1.6 kb deletion in the delta-globin gene (HBD) that removes the first two exons. We discuss the diagnostic challenges and clinical implications associated with this rare genetic combination, emphasizing the critical role of comprehensive molecular testing in accurately identifying complex thalassemia cases. This report contributes to the literature by documenting a novel [delta]-globin deletion in combination with a [beta]-thalassemia variant, providing valuable insights for clinicians and geneticists in the interpretation and management of atypical thalassemia profiles. Keywords: [beta]-Thalassemia, novel [delta]-globin deletion, normal Hb[A.sub.2], masked thalassemia, molecular diagnosis, next-generation sequencing
Publisher
Dove Medical Press Limited
Subject
